ArticleClinical and translational science2020

First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug.

Vincenzo Teneggi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.